News Focus
News Focus
Followers 147
Posts 26209
Boards Moderated 0
Alias Born 04/08/2004

Re: 12x post# 495020

Friday, 07/25/2025 8:11:36 PM

Friday, July 25, 2025 8:11:36 PM

Post# of 517638
Has anyone considered the one question for Anavex Life Sciences for Clock Stop#1 may be:

Do you Anavex Life Sciences have enough cash on hand to fund 3 months of the cost of producing enough blarcamesine for 3 months minimum for people within the EU? There are over 7 million people int the EU who have Alzheimer's and/or dimentia. If Anavex initially captures just 20% of threat 7 million that would be initially approximately 1.4million people taking initially 1 pill per day which means 365.25 days in a year or initially or 511.35 million blarcamesine pills per year at a minimum.

Blarcamesine needs 511.35 million blarcamesine pills per year at a minimum for just a 20% market capture of people with Alzheimer's and MCI in the EU.

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News